These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1152 related items for PubMed ID: 18352765

  • 1. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC, Bohman LE, Heyer G, Licursi M, Ghatan S, Feldstein NA, Anderson RC.
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [Abstract] [Full Text] [Related]

  • 2. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P, Steinberg GK.
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [Abstract] [Full Text] [Related]

  • 3. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ, Lebensburger JD, Chua MH, Fisher WS, Hilliard L, Bemrich-Stolz CJ, Howard TH, Johnston JM.
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [Abstract] [Full Text] [Related]

  • 4. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA, Armstrong D, Vachhrajani S, Dirks PB.
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [Abstract] [Full Text] [Related]

  • 5. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER, McClain CD, Heeney M, Scott RM.
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [Abstract] [Full Text] [Related]

  • 6. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
    Kennedy BC, McDowell MM, Yang PH, Wilson CM, Li S, Hankinson TC, Feldstein NA, Anderson RC.
    Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
    [Abstract] [Full Text] [Related]

  • 7. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T, Shirane R, Fujimura M, Tominaga T.
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [Abstract] [Full Text] [Related]

  • 8. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
    Fryer RH, Anderson RC, Chiriboga CA, Feldstein NA.
    Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
    [Abstract] [Full Text] [Related]

  • 9. Modified encephaloduroarteriosynangiosis with bifrontal encephalogaleoperiosteal synangiosis for the treatment of pediatric moyamoya disease. Technical note.
    Park JH, Yang SY, Chung YN, Kim JE, Kim SK, Han DH, Cho BK.
    J Neurosurg; 2007 Mar; 106(3 Suppl):237-42. PubMed ID: 17465392
    [Abstract] [Full Text] [Related]

  • 10. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A, Hever P, Cheserem J, Gradil C, Bassi S, Tolias CM.
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [Abstract] [Full Text] [Related]

  • 11. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
    Khan N, Schuknecht B, Boltshauser E, Capone A, Buck A, Imhof HG, Yonekawa Y.
    Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
    [Abstract] [Full Text] [Related]

  • 12. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK, Stapleton CJ, Phillips MT, Walcott BP, Venteicher AS, Ogilvy CS.
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [Abstract] [Full Text] [Related]

  • 13. Moya Moya cases treated with encephaloduroarteriosynangiosis.
    Tripathi P, Tripathi V, Naik RJ, Patel JM.
    Indian Pediatr; 2007 Feb; 44(2):123-7. PubMed ID: 17351302
    [Abstract] [Full Text] [Related]

  • 14. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N, Aronson JP, Manjila S, Smith ER, Scott RM.
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [Abstract] [Full Text] [Related]

  • 15. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP, Ropper AE, Underberg DL, Robertson RL, Scott RM, Smith ER.
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [Abstract] [Full Text] [Related]

  • 16. Patients with moyamoya disease presenting with movement disorder.
    Pandey P, Bell-Stephens T, Steinberg GK.
    J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731
    [Abstract] [Full Text] [Related]

  • 17. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A, Smith ER, Robertson R, Scott RM.
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of one-stage direct revascularization and medicine therapy for treatment of ischemic moyamoya disease].
    Zhao H, You C.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Sep; 23(9):1097-100. PubMed ID: 19817297
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA.
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.